Intriguingly, we found that CAFs modulate the ER-α-induced transcriptome in a selective manner, conferring estrogen-independent growth in vivo by dampening much of the classical hormone-induced gene expression program, whilst retaining several hallmark pro-tumoral signaling pathways involved in basal-like differentiation, tumor invasiveness and therapeutic resistance. This evidence concerns the gene ESR1 and neoplasm.